Literature DB >> 12220248

Disseminated microsporidiosis in a renal transplant recipient.

A R Mohindra1, M W Lee, G Visvesvara, H Moura, R Parasuraman, G J Leitch, L Xiao, J Yee, R del Busto.   

Abstract

Disseminated microsporidiosis is diagnosed uncommonly in patients not infected with human immunodeficiency virus (HIV). We present a case of disseminated microsporidiosis in a renal transplant recipient who was seronegative for HIV. Chromotrope-based stains were positive for microsporidia in urine, stools, sputum, and conjunctival scrapings. Electron microscopy, immunofluorescence, polymerase chain reaction, and cultures of renal tissue identified the organism as Encephalitozoon cuniculi. The patient was treated with oral albendazole and topical fumagillin with clinical improvement. In addition, she underwent a transplant nephrectomy and immunosuppressive therapy was withdrawn. Follow-up samples were negative for microsporidia. However, the patient developed central nervous system manifestations and died. An autopsy brain tissue specimen demonstrated E. cuniculi by immunofluorescent staining. Disseminated microsporidiosis must be considered in the differential diagnosis of multiorgan involvement in renal allograft recipients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220248     DOI: 10.1034/j.1399-3062.2002.01011.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  19 in total

1.  Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen.

Authors:  Christina M Coyle; Louis M Weiss; Luther V Rhodes; Ann Cali; Peter M Takvorian; Daniel F Brown; Govinda S Visvesvara; Lihua Xiao; Jaan Naktin; Eric Young; Marcelo Gareca; Georgia Colasante; Murray Wittner
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

2.  Disseminated infection with a new genovar of Encephalitozoon cuniculi in a renal transplant recipient.

Authors:  Hana Talabani; Claudine Sarfati; Evangeline Pillebout; Tom van Gool; Francis Derouin; Jean Menotti
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

Review 3.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

Review 4.  First cases of microsporidiosis in transplant recipients in Spain and review of the literature.

Authors:  A L Galván; A M Martín Sánchez; M A Pérez Valentín; N Henriques-Gil; F Izquierdo; S Fenoy; C del Aguila
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

5.  Monoclonal antibodies for specific detection of Encephalitozoon cuniculi.

Authors:  Lan Mo; Michel Drancourt
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

6.  Detecting immunoglobulin M antibodies against microsporidian Encephalitozoon cuniculi polar tubes in sera from healthy and human immunodeficiency virus-infected persons in Japan.

Authors:  Mako Omura; Koji Furuya; Shinichi Kudo; Wataru Sugiura; Hiroshi Azuma
Journal:  Clin Vaccine Immunol       Date:  2006-11-15

Review 7.  Zoonotic potential of the microsporidia.

Authors:  Alexander Mathis; Rainer Weber; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

8.  Detection and identification of Enterocytozoon bieneusi and Encephalitozoon species in stool and urine specimens by PCR and differential hybridization.

Authors:  Daan W Notermans; Ron Peek; Menno D de Jong; Ellen M Wentink-Bonnema; René Boom; Tom van Gool
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

9.  Chronic Infections in Mammals Due to Microsporidia.

Authors:  Bohumil Sak; Martin Kváč
Journal:  Exp Suppl       Date:  2022

10.  Induction of a rapid and strong antigen-specific intraepithelial lymphocyte response during oral Encephalitozoon cuniculi infection.

Authors:  Magali Moretto; Louis M Weiss; Imtiaz A Khan
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.